AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs

Summit shares surged in after-hours trading following the news of AstraZeneca's investment, as the two companies plan to ramp up their collaboration on developing cancer treatments.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。